$CRSP CRISPR Therapeutics AG Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CRISPR Therapeutics AG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in CRISPR Therapeutics AG. Find out how many shares they currently own, their value and whether they buy or sell their shares.
CRISPR Therapeutics AG Insiders
Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
---|---|---|---|---|---|---|---|
BAYER AKTIENGESELLSCHAFT | 10% Owner | 5,632,802 | 88,716,632 | Jan 30 2018 | |||
Behbahani Ali | Director | 256 | 4,032 | Aug 14 2020 | |||
Bolzon Bradley J PhD | Director | 57,149 | 900,097 | Mar 24 2021 | |||
CAGNONI PABLO J | Director | 7,500 | 118,125 | Nov 21 2019 | |||
CELGENE CORP /DE/ | 10% Owner | 4,812,221 | 75,792,481 | Dec 07 2017 | |||
COLES N ANTHONY | Director | 70,000 | 1,102,500 | Oct 26 2016 | |||
Dylan-Hyde Tyler | Chief Legal Officer | 25,204 | 396,963 | Jan 18 2018 | |||
EMSTER KURT VON | Director | 1,234,193 | 19,438,540 | Dec 19 2018 | |||
George Simeon | Director | 2,942,560 | 46,345,320 | Jun 15 2020 | |||
GLAXOSMITHKLINE PLC | 10% Owner | 2,942,560 | 46,345,320 | Oct 26 2016 | |||
Greene John | Director | 0 | 0 | Jun 15 2020 | |||
Hadley Harbor Master Investors (Cayman) L.P. | 10% Owner | 744,380 | 11,723,985 | Oct 24 2016 | |||
High Katherine A | Director | 0 | 0 | Jun 15 2020 | |||
Ho Tony W | Executive VP, Head of R&D | 40,445 | 637,009 | Mar 12 2021 | |||
KASINGER JAMES R. | General Counsel and Secretary | 25,264 | 397,908 | Mar 12 2021 | |||
Klein Lawrence Otto | CBO & COO | 25,050 | 394,538 | Mar 25 2021 | |||
Kulkarni Samarth | Chief Executive Officer | 217,719 | 3,429,074 | Jun 17 2021 | |||
Lundberg Sven Ante | Chief Scientific Officer | 505,217 | 7,957,168 | Feb 10 2017 | |||
Novak Rodger | President | 698,007 | 10,993,610 | Dec 02 2020 | |||
Subramanian Kala | See Remarks | 0 | 0 | Jun 19 2017 | |||
TOMSICEK MICHAEL JOHN | Chief Financial Officer | 3,243 | 51,077 | Mar 12 2021 | |||
Treco Douglas A | Director | 0 | 0 | Jun 15 2020 | |||
Versant Venture Capital IV, L.P. | 10% Owner | 2,238,979 | 35,263,919 | Apr 24 2018 | |||
Versant Venture Capital V, L.P. | 10% Owner | 1,519,505 | 23,932,204 | Apr 26 2018 | |||
Vertex Pharmaceuticals (Europe) Ltd | 10% Owner | 5,353,479 | 84,317,294 | Dec 28 2018 | |||
Woiwode Thomas | Director | 641,014 | 10,095,971 | Jun 15 2018 |